Immunogenicity 12087
Sample ID
3998
Response
Negative
Tumor Type
Melanoma
Gene Symbol
MOB2
Transcript ID
uc001ltp.1
HLA INFO
A*01:01
TCR INFO
No TCR info found!
Full length protein sequence (255 aa)
MQRGR
1
RGPQW
6
GQWGW
11
GRQRG
16
PGSTE
21
PREGE
26
MSPPG
31
RTGAH
36
VCKET
41
VVCVL
46
SCICV
51
CTHVL
56
GTRVV
61
RSERA
66
PGCTG
71
VGCTG
76
TDADG
81
PGRVL
86
WPPVG
91
WMRAV
96
CREEP
101
LGPFT
106
RSADT
111
HGTDA
116
LSFLL
121
WGFPF
126
SGLRA
131
APALP
136
RVLLA
141
SKEEL
146
VGGGC
151
DLQTW
156
VSALL
161
WGWGL
166
LSQRP
171
SFPLT
176
PPLPA
181
SPGVL
186
AVGSS
191
EVGEA
196
CGVRC
201
PAPAP
206
APVTP
211
SCCLL
216
HAQGT
221
PMVQS
226
SGKAR
231
TGLRP
236
CVEML
241
HQRKA
246
ETRLP
251
Mutation Information
DNA mutation:
None
Peptide Range:
164 ~ 188
Mut AA position:
176 (13 in Wild Type peptide)
Alignment
Wild Type:
"LLWGWGLLSQRPSFPLTPPLPASPG
||||||||||||.||||||||||||
Mutant:
LLWGWGLLSQRPFFPLTPPLPASPG"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) MOB2
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
COS7
Assay
IFNg ELISPOT assay